Evidence map›Paper›PMID 41756397›Full record

ArticleFrontiers in antibiotics2026

Phage biobanks as enabling infrastructure for precision phage therapy in the era of antimicrobial resistance.

Paulina Topa-Pila, Katheryne Y Morales, Doménica P Palacios-Mora, Cristina Flores-Hernández, Analía Altamirano-Cisneros, Joselyn Micaela Gavilanes, Keyla Villacís-López, Mirari Arancibia, Johanna Mora-Domínguez, William Calero-Cáceres

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in antibiotics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Paulina Topa-PilaBiotechnology Program, Department of Food and Biotechnology Science and Engineering, Universidad Técnica de Ambato, Ambato, Ecuador.
Katheryne Y MoralesBiotechnology Program, Department of Food and Biotechnology Science and Engineering, Universidad Técnica de Ambato, Ambato, Ecuador.
Doménica P Palacios-MoraClínica Santa Ana, Cuenca, Ecuador.
Cristina Flores-HernándezDepartamento de Ciencias Exactas Sede Latacunga, Universidad de las Fuerzas Armadas ESPE, Rumiñahui, Ecuador.
Analía Altamirano-CisnerosBiotechnology Program, Department of Food and Biotechnology Science and Engineering, Universidad Técnica de Ambato, Ambato, Ecuador.
Joselyn Micaela GavilanesBiotechnology Program, Department of Food and Biotechnology Science and Engineering, Universidad Técnica de Ambato, Ambato, Ecuador.
Keyla Villacís-LópezBiotechnology Program, Department of Food and Biotechnology Science and Engineering, Universidad Técnica de Ambato, Ambato, Ecuador.
Mirari ArancibiaBiotechnology Program, Department of Food and Biotechnology Science and Engineering, Universidad Técnica de Ambato, Ambato, Ecuador.
Johanna Mora-DomínguezHospital de Especialidades José Carrasco Arteaga, Instituto Ecuatoriano de Seguridad Social (IESS), Cuenca, Ecuador.
William Calero-CáceresBiotechnology Program, Department of Food and Biotechnology Science and Engineering, Universidad Técnica de Ambato, Ambato, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The renewed interest in bacteriophage therapy as a response to antimicrobial resistance (AMR) has exposed a critical barrier to its scalable implementation: the lack of structured infrastructure to support precision phage deployment. Due to their narrow host specificity, bacteriophages require timely access to well-matched candidates, making

Indexed as

antimicrobial resistance (AMR)bioinformaticsOne healthphage biobanksphage therapyprecision medicine

Identifiers

PMID41756397
PMCPMC12933349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.